Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin

被引:71
作者
Gysler, A
Kleuser, B
Sippl, W
Lange, K
Korting, HC
Höltje, HD
Schäfer-Korting, M
机构
[1] Free Univ Berlin, Inst Pharm, Abt Pharmakol & Toxikol, D-14195 Berlin, Germany
[2] Univ Dusseldorf, Inst Pharm, D-4000 Dusseldorf, Germany
[3] Univ Munich, Dermatol Klin & Poliklin, D-8000 Munich, Germany
关键词
benefit/risk ratio; drug metabolism; prednicarbate; skin penetration; topical glucocorticoids;
D O I
10.1023/A:1018946924585
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To investigate pharmacokinetic differences between the nonhalogenated double ester prednicarbate (PC) and the fluorinated monoester betamethasone 17-valerate (BM17V) their metabolism in human keratinocytes and fibroblasts as well as their permeation and biotransformation in reconstructed epidermis and excised human skin was compared. Special attention was given to the 17-monoesters because of their high receptor affinity and antiproliferative effects. Methods. Glucocorticoid penetration was determined using Franz diffusion cells, quantifying metabolite concentrations by HPLC. Chemical stability and reactivity of the monoesters was determined by molecular modeling analysis. Results. PC accumulated in the stratum corneum. A considerable amount of penetrating PC was hydrolyzed by viable keratinocytes to prednisolone 17-ethylcarbonate (P17EC). P17EC permeated the skin very rapidly when compared to BM17V. Overall P17EC concentrations in viable tissue were low. Inside of the acceptor fluid, but not within the tissue, P17EC was converted to the more stable prednisolone 21-ethylcarbonate (P21EC). Conclusions. The inactivation of highly potent, but also cell toxic, 17-monoesters to almost inactive 21-congeners seen with isolated cell monolayers appears less important in the skin. In vitro determination of the dermal 17-monoesters concentrations may allow the prediction of the atrophogenic risk in man. BM17V levels exceeding P17EC concentrations about 6-fold may contribute to its lower tolerance when compared to PC.
引用
收藏
页码:1386 / 1391
页数:6
相关论文
共 21 条
[1]  
BODOR N, 1988, TOPICAL CORTICOSTERO, P13
[2]   MAINTENANCE OF SKIN VIABILITY DURING INVITRO PERCUTANEOUS ABSORPTION-METABOLISM STUDIES [J].
COLLIER, SW ;
SHEIKH, NM ;
SAKR, A ;
LICHTIN, JL ;
STEWART, RF ;
BRONAUGH, RL .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1989, 99 (03) :522-533
[3]   GENERAL PARAMETERIZED SCF MODEL FOR FREE-ENERGIES OF SOLVATION IN AQUEOUS-SOLUTION [J].
CRAMER, CJ ;
TRUHLAR, DG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (22) :8305-8311
[4]   THE DEVELOPMENT AND USE OF QUANTUM-MECHANICAL MOLECULAR-MODELS .76. AM1 - A NEW GENERAL-PURPOSE QUANTUM-MECHANICAL MOLECULAR-MODEL [J].
DEWAR, MJS ;
ZOEBISCH, EG ;
HEALY, EF ;
STEWART, JJP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1985, 107 (13) :3902-3909
[5]   Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts [J].
Gysler, A ;
Lange, K ;
Korting, HC ;
SchaferKorting, M .
PHARMACEUTICAL RESEARCH, 1997, 14 (06) :793-797
[6]  
GYSLER A, IN PRESS DO IT IN VI
[7]  
HOLTJE HD, 1996, MOL MODELLING BASIC
[8]   SKIN PERMEABILITY - DERMATOLOGIC ASPECTS OF TRANSDERMAL DRUG DELIVERY [J].
KLIGMAN, AM .
AMERICAN HEART JOURNAL, 1984, 108 (01) :200-206
[9]   0.25-PERCENT PREDNICARBATE CREAM AND THE CORRESPONDING VEHICLE INDUCE LESS SKIN ATROPHY THAN 0.1-PERCENT BETAMETHASONE-17-VALERATE CREAM AND 0.05-PERCENT CLOBETASOL-17-PROPIONATE CREAM [J].
KORTING, HC ;
VIELUF, D ;
KERSCHER, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 42 (02) :159-161
[10]  
LANGE K, 1997, PHARMACEUT RES, V14, P7744